[3H]U-69593 labels a subtype of kappa opiate receptor with characteristics different from that labeled by [3H]ethylketocyclazocine (original) (raw)

COMPARISON OF THE RECEPTOR BINDING CHARACTERISTICS OF OPIATE AGONISTS INTERACTING WITH μ- OR K-RECEPTORS

Kenneth Vaux

British Journal of Pharmacology, 1978

View PDFchevron_right

Cloning and Pharmacological Characterization of a Rat kappa Opioid Receptor

Fan Meng

Proceedings of The National Academy of Sciences, 1993

View PDFchevron_right

Pharmacological profiles of opioid ligands at kappa opioid receptors

Parham Gharagozlou

BMC pharmacology, 2006

View PDFchevron_right

Antagonists of the kappa opioid receptor

Miguel Guerrero

Bioorganic & Medicinal Chemistry Letters, 2014

View PDFchevron_right

The opioid receptor binding of dezocine, morphine, fentanyl, butorphanol and nalbuphine

Fishman Jordan

Life Sciences, 1993

View PDFchevron_right

Editorial: Kappa opioid receptors revealed: Disentangling the pharmacology to open up new therapeutic strategies

Marta Valenza

Frontiers in Pharmacology

View PDFchevron_right

Mu-opioid component of the ethylketocyclazocine (EKC) discriminative stimulus in the rat

Stuart Fielding

Psychopharmacology, 1989

View PDFchevron_right

PHARMACOKINETICS INVOLVED WITH KAPPA OPIOID RECEPTORS (Atena Editora)

Atena Editora

PHARMACOKINETICS INVOLVED WITH KAPPA OPIOID RECEPTORS (Atena Editora), 2022

View PDFchevron_right

Opiate receptors: an introduction

John Carmody

Anaesthesia and intensive care, 1987

View PDFchevron_right

κ-Opioid receptors are differentially labeled by arylacetamides and benzomorphans

Jean Bidlack

European Journal of Pharmacology, 2004

View PDFchevron_right

Differential Agonist Regulation of the Human κ-Opioid Receptor

George Bot

Journal of Neurochemistry, 2002

View PDFchevron_right

Interactions between kappa and mu opioid receptor agonists: effects of the ratio of drugs in mixtures

Daniela Osteicoechea

Psychopharmacology, 2018

View PDFchevron_right

[ 3 H]U69,593 binding in guinea-pig brain: comparison with [ 3 H]ethylketazocine binding at the κ-opioid sites

Mario Tiberi

Canadian Journal of Physiology and Pharmacology, 1988

View PDFchevron_right

Evaluation of the kappa-opioid receptor-selective tracer [ 11 C]GR103545 in awake rhesus ma

Gjermund Henriksen

Eur J Nucl Med Mol Imaging, 2010

View PDFchevron_right

Pharmacological characterization of the binding of [ 3 H]bremazocine in guinea-pig brain: evidence for multiplicity of the κ-opioid receptors

Mario Tiberi

Canadian Journal of Physiology and Pharmacology, 1989

View PDFchevron_right

Contribution of mu and delta opioid receptors to the pharmacological profile of kappa opioid receptor subtypes

Richard van Rijn

European Journal of Pain, 2012

View PDFchevron_right

Evaluation of the kappa-opioid receptor-selective tracer [11C]GR103545 in awake rhesus macaques

Gjermund Henriksen

European Journal of Nuclear Medicine and Molecular Imaging, 2010

View PDFchevron_right

Leucine enkephalin noncompetitively inhibits the binding of [3H]naloxone to the opiate mu-recognition site: Evidence for delta←mu binding site interactions in vitro

Janine Danks

Neuropeptides, 1985

View PDFchevron_right

Improved assays for the assessment of ϰ- and δ-properties of opioid ligands

susan j ward

European Journal of Pharmacology, 1982

View PDFchevron_right

Autoradiography of [3H]U-69593 binding sites in rat brain: evidence for κ opioid receptor subtypes

Theodore Cicero

European Journal of Pharmacology, 1988

View PDFchevron_right

Kappa opioid binding sites on the R1.1 murine lymphoma cell line: sensitivity to cations and guanine nucleotides

Jean Bidlack

Journal of Neuroimmunology, 1992

View PDFchevron_right

2013-02-BMC PharmacolTox-opioid receptors-Supp

Robert Levenson

View PDFchevron_right

Comparison of the stimulus effects of ethylketocyclazocine in fischer and Sprague-Dawley rats

Stuart Fielding

Drug Development Research, 1991

View PDFchevron_right

Molecular biology and pharmacology of cloned opioid receptors. FASEB J 9:516-525

Victor Hruby is to

The FASEB Journal

View PDFchevron_right

Pharmacological and anatomical evidence of selective μ, δ, and χ opioid receptor binding in rat brain

Stan Watson

Brain Research, 1986

View PDFchevron_right

Tyr-D-Ala-Gly-(Me)Phe-chloromethyl ketone: A specific affinity label for the opioid receptor

Sndor Benyhe, Anna Borsodi

Neuropeptides, 1987

View PDFchevron_right

Characterizing ?3 opioid receptors with a selective monoclonal antibody

Grace Rossi

Synapse, 1996

View PDFchevron_right

Agonist‐Induced Phosphorylation of the κ‐Opioid Receptor

Wenzhen Jin

Journal of Neurochemistry, 2002

View PDFchevron_right

Differentiation of delta, mu, and kappa opioid receptor agonists based on pharmacophore development and computed physicochemical properties

Hugo Villar

Journal of Computer Aided Molecular Design, 2001

View PDFchevron_right

The Kappa-Opiate Receptor Impacts the Pathophysiology and Behavior of Substance Use

David Mysels

American Journal on Addictions, 2009

View PDFchevron_right

Mu and kappa opioids inhibit transmitter release by different mechanisms

A. Cherubini

Proceedings of the National Academy of Sciences of the United States of America, 1985

View PDFchevron_right

Human native kappa opioid receptor functions not predicted by recombinant receptors: Implications for drug design

G. Sanger

Scientific reports, 2016

View PDFchevron_right

Agonist-Dependent And -Independent Kappa Opioid Receptor Phosphorylation Showed Distinct Phosphorylation Patterns And Resulted In Different Cellular Outcomes

Lee-Yuan Liu-Chen

2017

View PDFchevron_right

A Monoclonal Antibody Recognizing K- but Not ?- and ?-Opioid Receptors

Sándor Benyhe

Journal of Neurochemistry, 1991

View PDFchevron_right